Lab-Made Antibodies: Rapidly Developed Treatments for New Epidemics
Introduction In fighting infectious diseases, antibodies are a key part of our immune arsenal. Over the past decades, scientists have learned to replicate and engineer these proteins in the lab, producing monoclonal antibodies (mAbs) tha...
Read MoreNanotech in Medicine: Nanoparticles Hunting Down Cancer Cells
Introduction One of the biggest challenges in oncology is delivering potent anti-cancer drugs directly to tumor cells while sparing healthy tissues . Nanotechnology offers an innovative solution. By engineering nanoparticles that selectively b...
Read MorePhage Therapy: Using Viruses to Defeat Antibiotic-Resistant Bacteria
Introduction Antibiotic resistance is a growing global crisis, jeopardizing our ability to treat common infections and secure safe medical procedures. As bacteria evolve to evade standard drugs, scientists are reviving an age-old approach: bacter...
Read MoreFecal Transplants 2.0: Next Generation Probiotics to Cure Disease
Introduction For decades, fecal microbiota transplantation (FMT)—transferring stool from a healthy donor to a recipient—has helped combat stubborn gut infections like Clostridioides difficile (C. diff). Its success has sparked a new wave of i...
Read MoreMicrobiome Medicine: Using Gut Bacteria to Treat Diseases
Introduction We increasingly understand that the human microbiome—the trillions of bacteria, viruses, and other microbes living in our intestines—plays a pivotal role in our well-being . From digestion to immune regulation, these microorga...
Read More